Staphylococcus aureus (S. aureus, or ‘golden staph’) bloodstream infections (SABSI) associated with hospital care can be serious, particularly when bacteria are resistant to common antimicrobials.
In 2019–20, all states and territories had public hospital SABSI rates below the national benchmark of 2.0 cases per 10,000 patient days.
Over the past 5 years, the SABSI rate has fluctuated at around 0.7, for instance, 0.74 in 2015–16 and 0.71 in 2019–20.
- Cat. no: HSE 240
In 2019–20 public hospitals had 1,428 SABSI cases during 20.1 million days of patient care under surveillance
Nationally, public hospital SABSI rates fluctuated between 0.74–0.71 cases per 10,000 patient days over the past 5 years
All states and territories had a SABSI rate lower than the national benchmark of 2.0 cases per 10,000 patient days
83% of public hospital SABSI cases were treatable with commonly used antibiotics